ArticleTherapeutics and clinical risk management2015
Bivalirudin plus loading dose of cilostazol-based triple-antiplatelet in treatment of non-ST-elevation myocardial infarction following percutaneous coronary intervention.
Mei Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.